Abbott LaboratoriesABTNYSE
Loading
Operating Income Growth TrendStable
Percentile Rank71
5Y CAGR+3.3%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+3.3%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive growthStable
| Period | Value |
|---|---|
| 2025 | 17.92% |
| 2024 | 6.06% |
| 2023 | -23.04% |
| 2022 | -9.11% |
| 2021 | 73.88% |
| 2020 | 15.25% |
| 2019 | 19.43% |
| 2018 | 94.93% |
| 2017 | -39.30% |
| 2016 | 10.17% |